ArticleFrontiers in oncology2022

Adjuvant chemotherapy is not a decisive factor in improving the overall survival of pulmonary sarcoma: A population-based study.

Long Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.